Syndromic Hearing Loss: A Brief Review of Common Presentations and Genetics

John D. Gettelfinger; John P. Dahl

doi:10.1055/s-0037-1617454

Journal of Pediatric Genetics, Table of Contents

J Pediatr Genet 2018; 07(01): 001-008
DOI: 10.1055/s-0037-1617454

Review Article

Georg Thieme Verlag KG Stuttgart · New York

Syndromic Hearing Loss: A Brief Review of Common Presentations and Genetics

John D. Gettelfinger

¹Department of Otolaryngology – Head and Neck Surgery, Indiana University School of Medicine, Indianapolis, Indiana, United States

,

John P. Dahl

¹Department of Otolaryngology – Head and Neck Surgery, Indiana University School of Medicine, Indianapolis, Indiana, United States

› Author Affiliations

Abstract

Congenital hearing loss is one of the most common birth defects worldwide, with around 1 in 500 people experiencing some form of severe hearing loss. While over 400 different syndromes involving hearing loss have been described, it is important to be familiar with a wide range of syndromes involving hearing loss so an early diagnosis can be made and early intervention can be pursued to maximize functional hearing and speech-language development in the setting of verbal communication. This review aims to describe the presentation and genetics for some of the most frequently occurring syndromes involving hearing loss, including neurofibromatosis type 2, branchio-oto-renal syndrome, Treacher Collins syndrome, Stickler syndrome, Waardenburg syndrome, Pendred syndrome, Jervell and Lange-Nielsen syndrome, Usher syndromes, Refsum disease, Alport syndrome, MELAS, and MERRF.

Keywords

hearing loss - syndromic - sensorineural

Full Text

References

References
1 Morton NE. Genetic epidemiology of hearing impairment. Ann N Y Acad Sci 1991; 630 (01) 16-31
2 Smith RJ, Bale Jr JF, White KR. Sensorineural hearing loss in children. Lancet 2005; 365 (9462): 879-890
3 Li XC, Friedman RA. Nonsyndromic hereditary hearing loss. Otolaryngol Clin North Am 2002; 35 (02) 275-285
4 Slattery WH. Neurofibromatosis type 2. Otolaryngol Clin North Am 2015; 48 (03) 443-460
5 Strasnick B, Glasscock III MEI, Haynes D, McMenomey SO, Minor LB. The natural history of untreated acoustic neuromas. Laryngoscope 1994; 104 (09) 1115-1119
6 Briggs RJ, Brackmann DE, Baser ME, Hitselberger WE. Comprehensive management of bilateral acoustic neuromas. Current perspectives. Arch Otolaryngol Head Neck Surg 1994; 120 (12) 1307-1314
7 Asthagiri AR, Parry DM, Butman JA. , et al. Neurofibromatosis type 2. Lancet 2009; 373 (9679): 1974-1986
8 Rouleau GA, Merel P, Lutchman M. , et al. Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2. Nature 1993; 363 (6429): 515-521
9 Bashour AM, Meng JJ, Ip W, MacCollin M, Ratner N. The neurofibromatosis type 2 gene product, merlin, reverses the F-actin cytoskeletal defects in primary human Schwannoma cells. Mol Cell Biol 2002; 22 (04) 1150-1157
10 Welling DB, Lasak JM, Akhmametyeva E, Ghaheri B, Chang L-S. cDNA microarray analysis of vestibular schwannomas. Otol Neurotol 2002; 23 (05) 736-748
11 Kalatzis V, Petit C. Branchio-Oto-Renal syndrome. Adv Otorhinolaryngol 2000; 56: 39-44
12 Chen A, Francis M, Ni L. , et al. Phenotypic manifestations of branchio-oto-renal syndrome. Am J Med Genet 1995; 58 (04) 365-370
13 Smith RJH, Schwartz C. Branchio-oto-renal syndrome. J Commun Disord 1998; 31 (05) 411-420 , quiz 421
14 Ceruti S, Stinckens C, Cremers CW, Casselman JW. Temporal bone anomalies in the branchio-oto-renal syndrome: detailed computed tomographic and magnetic resonance imaging findings. Otol Neurotol 2002; 23 (02) 200-207
15 Fraser FC, Sproule JR, Halal F, Optiz JM. Frequency of the branchio-oto-renal (BOR) syndrome in children with profound hearing loss. Am J Med Genet 1980; 7 (03) 341-349
16 Abdelhak S, Kalatzis V, Heilig R. , et al. A human homologue of the Drosophila eyes absent gene underlies branchio-oto-renal (BOR) syndrome and identifies a novel gene family. Nat Genet 1997; 15 (02) 157-164
17 Kalatzis V, Abdelhak S, Compain S, Vincent C, Petit C. Characterization of a translocation-associated deletion defines the candidate region for the gene responsible for branchio-oto-renal syndrome. Genomics 1996; 34 (03) 422-425
18 Ruf RG, Xu PX, Silvius D. , et al. SIX1 mutations cause branchio-oto-renal syndrome by disruption of EYA1-SIX1-DNA complexes. Proc Natl Acad Sci U S A 2004; 101 (21) 8090-8095
19 Hoskins BE, Cramer CH, Silvius D. , et al. Transcription factor SIX5 is mutated in patients with branchio-oto-renal syndrome. Am J Hum Genet 2007; 80 (04) 800-804
20 Tadjuidje E, Hegde RS. The EYES absent proteins in development and disease. Cell Mol Life Sci 2013; 70 (11) 1897-1913
21 Trainor PA, Dixon J, Dixon MJ. Treacher Collins syndrome: etiology, pathogenesis and prevention. Eur J Hum Genet 2009; 17 (03) 275-283
22 Stovin JJ, Lyon Jr JA, Clemmens RL. Mandibulofacial dysostosis. Radiology 1960; 74 (02) 225-231
23 Phelps PD, Poswillo D, Lloyd GA. The ear deformities in mandibulofacial dysostosis (Treacher Collins syndrome). Clin Otolaryngol Allied Sci 1981; 6 (01) 15-28
24 Dixon J, Edwards SJ, Gladwin AJ. et al; The Treacher Collins Syndrome Collaborative Group. Positional cloning of a gene involved in the pathogenesis of Treacher Collins syndrome. Nat Genet 1996; 12 (02) 130-136
25 Fazen LE, Elmore J, Nadler HL. Mandibulo-facial dysostosis. (Treacher-Collins syndrome). Am J Dis Child 1967; 113 (04) 405-410
26 Rovin S, Dachi SF, Borenstein DB, Cotter WB. Mandibulofacial dysostosis, a familial study of five generations. J Pediatr 1964; 65: 215-221
27 Dauwerse JG, Dixon J, Seland S. , et al. Mutations in genes encoding subunits of RNA polymerases I and III cause Treacher Collins syndrome. Nat Genet 2011; 43 (01) 20-22
28 Kadakia S, Helman SN, Badhey AK, Saman M, Ducic Y. Treacher Collins syndrome: the genetics of a craniofacial disease. Int J Pediatr Otorhinolaryngol 2014; 78 (06) 893-898
29 Snead MP, Yates JRW. Clinical and molecular genetics of Stickler syndrome. J Med Genet 1999; 36 (05) 353-359
30 Stickler GB, Hughes W, Houchin P. Clinical features of hereditary progressive arthro-ophthalmopathy (Stickler syndrome): a survey. Genet Med 2001; 3 (03) 192-196
31 Weingeist TA, Hermsen V, Hanson JW, Bumsted RM, Weinstein SL, Olin WH. Ocular and systemic manifestations of Stickler's syndrome: a preliminary report. Birth Defects Orig Artic Ser 1982; 18 (06) 539-560
32 Nowak CB. Genetics and hearing loss: a review of Stickler syndrome. J Commun Disord 1998; 31 (05) 437-453 ; 453–454
33 Webb AC, Markus AF. The diagnosis and consequences of Stickler syndrome. Br J Oral Maxillofac Surg 2002; 40 (01) 49-51
34 Opitz JM, France T, Herrmann J, Spranger JW. The Stickler syndrome. N Engl J Med 1972; 286 (10) 546-547
35 Jacobson J, Jacobson C, Gibson W. Hearing loss in Stickler's syndrome: a family case study. J Am Acad Audiol 1990; 1 (01) 37-40
36 Lucarini JW, Liberfarb RM, Eavey RD. Otolaryngological manifestations of the Stickler syndrome. Int J Pediatr Otorhinolaryngol 1987; 14 (2-3): 215-222
37 Helfgott SM, Mosciscki RA, San Martin J. , et al. Correlation between antibodies to type II collagen and treatment outcome in bilateral progressive sensorineural hearing loss. Lancet 1991; 337 (8738): 387-389
38 Ahmad NN, Ala-Kokko L, Knowlton RG. , et al. Stop codon in the procollagen II gene (COL2A1) in a family with the Stickler syndrome (arthro-ophthalmopathy). Proc Natl Acad Sci U S A 1991; 88 (15) 6624-6627
39 Richards AJ, Yates JR, Williams R. , et al. A family with Stickler syndrome type 2 has a mutation in the COL11A1 gene resulting in the substitution of glycine 97 by valine in alpha 1 (XI) collagen. Hum Mol Genet 1996; 5 (09) 1339-1343
40 Vikkula M, Mariman EC, Lui VC. , et al. Autosomal dominant and recessive osteochondrodysplasias associated with the COL11A2 locus. Cell 1995; 80 (03) 431-437
41 Acke FR, Dhooge IJ, Malfait F, De Leenheer EM. Hearing impairment in Stickler syndrome: a systematic review. Orphanet J Rare Dis 2012; 7: 84 . doi: 10.1186/1750-1172-7-84
42 Van Camp G, Snoeckx RL, Hilgert N. , et al. A new autosomal recessive form of Stickler syndrome is caused by a mutation in the COL9A1 gene. Am J Hum Genet 2006; 79 (03) 449-457
43 Baker S, Booth C, Fillman C. , et al. A loss of function mutation in the COL9A2 gene causes autosomal recessive Stickler syndrome. Am J Med Genet A 2011; 155A (07) 1668-1672
44 Waardenburg PJ. A new syndrome combining developmental anomalies of the eyelids, eyebrows and noseroot with pigmentary anomalies of the iris and head hair and with congenital deafness; Dystopia canthi medialis et punctorum lacrimalium lateroversa, hyperplasia supercilii medialis et radicis nasi, heterochromia iridum totaliis sive partialis, albinismus circumscriptus (leucismus, polioss) et surditas congenita (surdimutitas). Am J Hum Genet 1951; 3 (03) 195-253
45 Read AP, Newton VE. Waardenburg syndrome. J Med Genet 1997; 34 (08) 656-665
46 Nayak CS, Isaacson G. Worldwide distribution of Waardenburg syndrome. Ann Otol Rhinol Laryngol 2003; 112 (9 Pt 1): 817-820
47 Cremers CWRJ, Smith RJH. , eds. Genetic Hearing Impairment: Its Clinical Presentations. Basel; New York: Karger; 2002
48 Liu XZ, Newton VE, Read AP. Waardenburg syndrome type II: phenotypic findings and diagnostic criteria. Am J Med Genet 1995; 55 (01) 95-100
49 Hoth CF, Milunsky A, Lipsky N, Sheffer R, Clarren SK, Baldwin CT. Mutations in the paired domain of the human PAX3 gene cause Klein-Waardenburg syndrome (WS-III) as well as Waardenburg syndrome type I (WS-I). Am J Hum Genet 1993; 52 (03) 455-462
50 Shah KN, Dalal SJ, Desai MP, Sheth PN, Joshi NC, Ambani LM. White forelock, pigmentary disorder of irides, and long segment Hirschsprung disease: possible variant of Waardenburg syndrome. J Pediatr 1981; 99 (03) 432-435
51 Zaman A, Capper R, Baddoo W. Waardenburg syndrome: more common than you think!. Clin Otolaryngol 2015; 40 (01) 44-48
52 Tassabehji M, Read AP, Newton VE. , et al. Waardenburg's syndrome patients have mutations in the human homologue of the Pax-3 paired box gene. Nature 1992; 355 (6361): 635-636
53 Sánchez-Martín M, Rodríguez-García A, Pérez-Losada J, Sagrera A, Read AP, Sánchez-García I. SLUG (SNAI2) deletions in patients with Waardenburg disease. Hum Mol Genet 2002; 11 (25) 3231-3236
54 Wenzhi H, Ruijin W, Jieliang L. , et al. Heterozygous deletion at the SOX10 gene locus in two patients from a Chinese family with Waardenburg syndrome type II. Int J Pediatr Otorhinolaryngol 2015; 79 (10) 1718-1721
55 Attié T, Till M, Pelet A. , et al. Mutation of the endothelin-receptor B gene in Waardenburg-Hirschsprung disease. Hum Mol Genet 1995; 4 (12) 2407-2409
56 Tassabehji M, Newton VE, Read AP. Waardenburg syndrome type 2 caused by mutations in the human microphthalmia (MITF) gene. Nat Genet 1994; 8 (03) 251-255
57 Bondurand N, Dastot-Le Moal F, Stanchina L. , et al. Deletions at the SOX10 gene locus cause Waardenburg syndrome types 2 and 4. Am J Hum Genet 2007; 81 (06) 1169-1185
58 Kopp P. Pendred's syndrome: identification of the genetic defect a century after its recognition. Thyroid 1999; 9 (01) 65-69
59 Morgans ME, Trotter WR. Association of congenital deafness with goitre; the nature of the thyroid defect. Lancet 1958; 1 (7021): 607-609
60 Pendred V. Deaf-mutism and goitre. Lancet 1896; 148 (3808): 532
61 Fugazzola L, Mannavola D, Cerutti N. , et al. Molecular analysis of the Pendred's syndrome gene and magnetic resonance imaging studies of the inner ear are essential for the diagnosis of true Pendred's syndrome. J Clin Endocrinol Metab 2000; 85 (07) 2469-2475
62 Reardon W, Coffey R, Phelps PD. , et al. Pendred syndrome–100 years of underascertainment?. QJM 1997; 90 (07) 443-447
63 Fraser GR. Association of congenital deafness with goitre (Pendred's syndrome): a study of 207 families. Ann Hum Genet 1965; 28 (1–3): 201-249
64 Bizhanova A, Kopp P. Genetics and phenomics of Pendred syndrome. Mol Cell Endocrinol 2010; 322 (1–2): 83-90
65 Everett LA, Glaser B, Beck JC. , et al. Pendred syndrome is caused by mutations in a putative sulphate transporter gene (PDS). Nat Genet 1997; 17 (04) 411-422
66 Pera A, Villamar M, Viñuela A. , et al. A mutational analysis of the SLC26A4 gene in Spanish hearing-impaired families provides new insights into the genetic causes of Pendred syndrome and DFNB4 hearing loss. Eur J Hum Genet 2008; 16 (08) 888-896
67 Jervell A, Lange-Nielsen F. Congenital deaf-mutism, functional heart disease with prolongation of the Q-T interval and sudden death. Am Heart J 1957; 54 (01) 59-68
68 Komsuoğlu B, Göldeli O, Kulan K. , et al. The Jervell and Lange-Nielsen syndrome. Int J Cardiol 1994; 47 (02) 189-192
69 Neyroud N, Tesson F, Denjoy I. , et al. A novel mutation in the potassium channel gene KVLQT1 causes the Jervell and Lange-Nielsen cardioauditory syndrome. Nat Genet 1997; 15 (02) 186-189
70 Tyson J, Tranebjaerg L, Bellman S. , et al. IsK and KvLQT1: mutation in either of the two subunits of the slow component of the delayed rectifier potassium channel can cause Jervell and Lange-Nielsen syndrome. Hum Mol Genet 1997; 6 (12) 2179-2185
71 Schulze-Bahr E, Wang Q, Wedekind H. , et al. KCNE1 mutations cause Jervell and Lange-Nielsen syndrome. Nat Genet 1997; 17 (03) 267-268
72 Öcal B, Imamoglu A, Atalay S, Ercan Tutar H. Prevalence of idiopathic long QT syndrome in children with congenital deafness. Pediatr Cardiol 1997; 18 (06) 401-405
73 Keats BJ, Corey DP. The Usher syndromes. Am J Med Genet 1999; 89 (03) 158-166
74 Petit C. Usher syndrome: from genetics to pathogenesis. Annu Rev Genomics Hum Genet 2001; 2 (01) 271-297
75 Smith RJ, Berlin CI, Hejtmancik JF. , et al; Usher Syndrome Consortium. Clinical diagnosis of the Usher syndromes. Am J Med Genet 1994; 50 (01) 32-38
76 Gorlin RJ, Tilsner TJ, Feinstein S, Duvall III AJ. Usher's syndrome type III. Arch Otolaryngol 1979; 105 (06) 353-354
77 Auffarth GU, Tetz MR, Krastel H, Blankenagel A, Völcker HE. Complicated cataracts in various forms of retinitis pigmentosa. Type and incidence [in German]. Ophthalmologe 1997; 94 (09) 642-646
78 Pennings RJE, Wagenaar M, van Aarem A, Huygen PLM, Kimberling WJ, Cremers CWRJ. Hearing Impairment in Usher's Syndrome. Vol. 61. Karger Publishers; 2002:184_191. Available at: http://www.karger.com/Article/Abstract/66832 . Accessed February 8, 2017
79 Weil D, Blanchard S, Kaplan J. , et al. Defective myosin VIIA gene responsible for Usher syndrome type 1B. Nature 1995; 374 (6517): 60-61
80 Ko MK, Kenderling WJ, Friedman RA. Genetics of ear disorders. In: Cummings Otolaryngology. 6th ed. Elsevier; 2015: 2275-2284
81 Eudy JD, Weston MD, Yao S. , et al. Mutation of a gene encoding a protein with extracellular matrix motifs in Usher syndrome type IIa. Science 1998; 280 (5370): 1753-1757
82 Weston MD, Eudy JD, Fujita S. , et al. Genomic structure and identification of novel mutations in usherin, the gene responsible for Usher syndrome type IIa. Am J Hum Genet 2000; 66 (04) 1199-1210
83 Boughman JA, Vernon M, Shaver KA. Usher syndrome: definition and estimate of prevalence from two high-risk populations. J Chronic Dis 1983; 36 (08) 595-603
84 Kimberling WJ, Hildebrand MS, Shearer AE. , et al. Frequency of Usher syndrome in two pediatric populations: implications for genetic screening of deaf and hard of hearing children. Genet Med 2010; 12 (08) 512-516
85 Davies MG, Marks R, Dykes PJ, Reynolds D. Epidermal abnormalities in Refsum's disease. Br J Dermatol 1977; 97 (04) 401-406
86 Jansen GA, Ofman R, Ferdinandusse S. , et al. Refsum disease is caused by mutations in the phytanoyl-CoA hydroxylase gene. Nat Genet 1997; 17 (02) 190-193
87 van den Brink DM, Brites P, Haasjes J. , et al. Identification of PEX7 as the second gene involved in Refsum disease. Am J Hum Genet 2003; 72 (02) 471-477
88 Steinberg D. The metabolic basis of the Refsum syndrome. Birth Defects Orig Artic Ser 1971; 7 (01) 42-52
89 Mihalik SJ, Morrell JC, Kim D, Sacksteder KA, Watkins PA, Gould SJ. Identification of PAHX, a Refsum disease gene. Nat Genet 1997; 17 (02) 185-189
90 Wanders RJA, Waterham HR, Leroy BP. Refsum disease. In: Pagon RA, Adam MP, Ardinger HH. , et al, eds. GeneReviews®. Seattle, WA: University of Washington, Seattle; 1993. . Available at: http://www.ncbi.nlm.nih.gov/books/NBK1353/ . Accessed February 11, 2017
91 Alport AC. Hereditary familial congenital haemorrhagic nephritis. BMJ 1927; 1 (3454): 504-506
92 Fallerini C, Dosa L, Tita R. , et al. Unbiased next generation sequencing analysis confirms the existence of autosomal dominant Alport syndrome in a relevant fraction of cases. Clin Genet 2014; 86 (03) 252-257
93 Flinter FA, Cameron JS, Chantler C, Houston I, Bobrow M. Genetics of classic Alport's syndrome. Lancet 1988; 2 (8618): 1005-1007
94 Plant KE, Green PM, Vetrie D, Flinter FA. Detection of mutations in COL4A5 in patients with Alport syndrome. Hum Mutat 1999; 13 (02) 124-132
95 Streeten BW, Robinson MR, Wallace R, Jones DB. Lens capsule abnormalities in Alport's syndrome. Arch Ophthalmol 1987; 105 (12) 1693-1697
96 Kashtan C. Alport syndrome: facts and opinions. F1000 Res 2017; 6: 50
97 Merchant SN, Burgess BJ, Adams JC. , et al. Temporal bone histopathology in Alport syndrome. Laryngoscope 2004; 114 (09) 1609-1618
98 Hashimura Y, Nozu K, Kaito H. , et al. Milder clinical aspects of X-linked Alport syndrome in men positive for the collagen IV α5 chain. Kidney Int 2014; 85 (05) 1208-1213
99 Plevová P, Gut J, Janda J. Familial hematuria: a review. Medicina (Kaunas) 2017; 53 (01) 1-10
100 Levy M, Feingold J. Estimating prevalence in single-gene kidney diseases progressing to renal failure. Kidney Int 2000; 58 (03) 925-943
101 Barker DF, Hostikka SL, Zhou J. , et al. Identification of mutations in the COL4A5 collagen gene in Alport syndrome. Science 1990; 248 (4960): 1224-1227
102 Morinière V, Dahan K, Hilbert P. , et al. Improving mutation screening in familial hematuric nephropathies through next generation sequencing. J Am Soc Nephrol 2014; 25 (12) 2740-2751
103 Pavlakis SG, Phillips PC, DiMauro S, De Vivo DC, Rowland LP. Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes: a distinctive clinical syndrome. Ann Neurol 1984; 16 (04) 481-488
104 Ensink RJ, Camp GV, Cremers CW. Mitochondrial inherited hearing loss. Clin Otolaryngol Allied Sci 1998; 23 (01) 3-8
105 Nadol Jr JB, Merchant SN. Histopathology and molecular genetics of hearing loss in the human. Int J Pediatr Otorhinolaryngol 2001; 61 (01) 1-15
106 Zwirner P, Wilichowski E. Progressive sensorineural hearing loss in children with mitochondrial encephalomyopathies. Laryngoscope 2001; 111 (03) 515-521
107 Goto Y, Nonaka I, Horai S. A mutation in the tRNA(Leu)(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature 1990; 348 (6302): 651-653
108 Shoffner JM, Lott MT, Lezza AMS, Seibel P, Ballinger SW, Wallace DC. Myoclonic epilepsy and ragged-red fiber disease (MERRF) is associated with a mitochondrial DNA tRNA(Lys) mutation. Cell 1990; 61 (06) 931-937
109 Wallace DC, Zheng XX, Lott MT. , et al. Familial mitochondrial encephalomyopathy (MERRF): genetic, pathophysiological, and biochemical characterization of a mitochondrial DNA disease. Cell 1988; 55 (04) 601-610